KS

Kartikey Singh

Active Director Individual Subscriber DIN 11572437
DIN 11572437 First appointment Feb 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kartikey Singh

Data last updated:

Kartikey Singh is an Individual Subscriber at Shoolin Pharmex Limited (since 2026) and Director at Arix Pharmex Limited (since 2026).

DIN 11572437
Primary Designation Individual Subscriber
First Appointment 25 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shoolin Pharmex Limited U21002GJ2026PLC183222
Individual Subscriber03 Sep 20262026Active
Arix Pharmex Limited U21002GJ2026PLC174204
Director25 Feb 20262026Active

Directorship timeline

Open interactive timeline →
Arix Pharmex Limited
Shoolin Pharmex Limited
Premium access

Shareholding and investment profile for Kartikey Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kartikey Singh

Kartikey Singh currently holds 2 directorships: Shoolin Pharmex Limited (Individual Subscriber, since 03 Sep 2026); Arix Pharmex Limited (Director, since 25 Feb 2026).

Kartikey Singh was first appointed on 25 Feb 2026 as Director at Arix Pharmex Limited.

The current boards of Kartikey Singh's companies include Abhisek Chand (Shoolin Pharmex Limited), Bimlesh Nandlal Shahani (Shoolin Pharmex Limited), Hemchandra Budhiraj Yadav (Shoolin Pharmex Limited), Madhu Chand (Shoolin Pharmex Limited), Mansi Bimlesh Shahani (Shoolin Pharmex Limited), Raju Thaneshwar Chand (Shoolin Pharmex Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available